Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg E Winter

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
Science (New York, N.Y.)|May 23, 2015
DRUG DEVELOPMENT. Phthalimide conjugation as a strategy for in vivo target protein degradationGeorg E Winter, Dennis L Buckley, Joshiawa Paulk, et al.
ACS Chemical Biology|May 13, 2015
Human Haploid Cell Genetics Reveals Roles for Lipid Metabolism Genes in Nonapoptotic Cell DeathScott J Dixon, Georg E Winter, Leila S Musavi, et al.
Molecular Cell|August 24, 2019
Plasticity of the Cullin-RING Ligase Repertoire Shapes Sensitivity to Ligand-Induced Protein DegradationCristina Mayor-Ruiz, Martin G Jaeger, Sophie Bauer, et al.
Scientific Reports|June 10, 2017
Lapatinib potentiates cytotoxicity of  YM155 in neuroblastoma via inhibition of the ABCB1 efflux transporterBranka Radic-Sarikas, Melinda Halasz, Kilian V M Huber, et al.
Nature Chemical Biology|November 4, 2022
Functional E3 ligase hotspots and resistance mechanisms to small-molecule degradersAlexander Hanzl, Ryan Casement, Hana Imrichova, et al.
Nature Communications|November 30, 2023
Discovery of a Drug-like, Natural Product-Inspired DCAF11 Ligand ChemotypeGang Xue, Jianing Xie, Matthias Hinterndorfer, et al.
Nature Communications|April 20, 2026
Disruption of the SAGA CORE triggers collateral degradation of KAT2APaul Batty, Hannah Beneder, Caroline Schätz, et al.
Journal of the American Chemical Society|January 5, 2023
E3-Specific Degrader Discovery by Dynamic Tracing of Substrate Receptor AbundanceAlexander Hanzl, Eleonora Barone, Sophie Bauer, et al.
Proteomics|May 11, 2010
MASPECTRAS 2: An integration and analysis platform for proteomic dataCeereena Ubaida Mohien, Jürgen Hartler, Florian Breitwieser, et al.
Molecular Cancer Therapeutics|July 20, 2011
An integrated chemical biology approach identifies specific vulnerability of Ewing's sarcoma to combined inhibition of Aurora kinases A and BGeorg E Winter, Uwe Rix, Andrej Lissat, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Science (New York, N.Y.)|May 23, 2015
DRUG DEVELOPMENT. Phthalimide conjugation as a strategy for in vivo target protein degradationGeorg E Winter, Dennis L Buckley, Joshiawa Paulk, et al.
ACS Chemical Biology|May 13, 2015
Human Haploid Cell Genetics Reveals Roles for Lipid Metabolism Genes in Nonapoptotic Cell DeathScott J Dixon, Georg E Winter, Leila S Musavi, et al.
Molecular Cell|August 24, 2019
Plasticity of the Cullin-RING Ligase Repertoire Shapes Sensitivity to Ligand-Induced Protein DegradationCristina Mayor-Ruiz, Martin G Jaeger, Sophie Bauer, et al.
Scientific Reports|June 10, 2017
Lapatinib potentiates cytotoxicity of  YM155 in neuroblastoma via inhibition of the ABCB1 efflux transporterBranka Radic-Sarikas, Melinda Halasz, Kilian V M Huber, et al.
Nature Chemical Biology|November 4, 2022
Functional E3 ligase hotspots and resistance mechanisms to small-molecule degradersAlexander Hanzl, Ryan Casement, Hana Imrichova, et al.
Nature Communications|November 30, 2023
Discovery of a Drug-like, Natural Product-Inspired DCAF11 Ligand ChemotypeGang Xue, Jianing Xie, Matthias Hinterndorfer, et al.
Nature Communications|April 20, 2026
Disruption of the SAGA CORE triggers collateral degradation of KAT2APaul Batty, Hannah Beneder, Caroline Schätz, et al.
Journal of the American Chemical Society|January 5, 2023
E3-Specific Degrader Discovery by Dynamic Tracing of Substrate Receptor AbundanceAlexander Hanzl, Eleonora Barone, Sophie Bauer, et al.
Proteomics|May 11, 2010
MASPECTRAS 2: An integration and analysis platform for proteomic dataCeereena Ubaida Mohien, Jürgen Hartler, Florian Breitwieser, et al.
Molecular Cancer Therapeutics|July 20, 2011
An integrated chemical biology approach identifies specific vulnerability of Ewing's sarcoma to combined inhibition of Aurora kinases A and BGeorg E Winter, Uwe Rix, Andrej Lissat, et al.
Pageof 8